Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors

To explore the potential use of CDK inhibitors in pancreatic ductal adenocarcinoma (PDAC) therapy, a series of novel 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives was designed, synthesised, and investigated for inhibition on both CDK kinase activity and cellular proliferation of...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Bo Yang, Yanni Quan, Wuli Zhao, Yingjie Ji, Xiaotang Yang, Jianrui Li, Yi Li, Xiujun Liu, Ying Wang, Yanping Li
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Taylor & Francis Group 2023-12-01
سلاسل:	Journal of Enzyme Inhibition and Medicinal Chemistry
الموضوعات:	Cell cycle-dependent kinase inhibitor 2-((4-sulfamoylphenyl)amino)-pyrrolo[23-d]pyrimidine derivatives pancreatic ductal adenocarcinoma anti-proliferative activity oral pharmacokinetics
الوصول للمادة أونلاين:	https://www.tandfonline.com/doi/10.1080/14756366.2023.2169282
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!